Navigation Links
Center to revolutionize chemical manufacture is open for business

An EPSRC (Engineering and Physical Sciences Research Council) Centre for revolutionising the way pharmaceuticals and other chemicals are made is being officially launched today (Friday, 8 April).

The collaborative initiative involving leading academics and industrialists, led by the University of Strathclyde in Glasgow, is seeking quicker, more effective and more sustainable methods of manufacturing products such as medicines, foodstuffs, dyes, pigments and nanomaterials.

The research team plans to develop a better understanding of the way these products form and to improve ways to control this, using new processes for manufacturing. The chemical and pharmaceutical sectors are worth 113 billion to the UK economy annually in sales and the new national EPSRC centre will improve and accelerate the production of a broad range of products.

In particular, by delivering better control over the process of crystallisation, the research team will create new opportunities for innovation in solid chemical products such as pharmaceuticals.

The new Centre will allow leading research teams to work together to develop technologies that ensure medicines and other materials can be produced using continuous manufacturing approaches, rather than using traditional batch methods. A key aspect to this is developing crystallisation technologies that deliver better control than is currently possible. In addition to the more efficient use of materials and resources, these techniques offer the opportunity to reduce running costs by up to 60% and energy requirements by up to 70%.

Strathclyde is leading the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation, which also involves the Universities of Bath, Cambridge, Edinburgh, Glasgow, Heriot-Watt and Loughborough. Substantial support is also being provided by industry partners that include GlaxoSmithKline, Pfizer, AstraZeneca, Fujifilm, British Salt, Croda International plc, Genzyme Ltd, NiTech Solutions, Phoenix Chemicals and Solid Form Solutions Ltd.

Professor Alastair Florence, of the Strathclyde Institute of Pharmacy and Biomedical Sciences, is Director of the new Centre. He said: "We are delighted to be establishing this new EPSRC Centre that brings together leading academic expertise in crystallisation, analysis, chemistry, formulation and manufacturing from across the UK.

"This unique national Centre will provide a focus for early stage engineering and physical sciences research that will ultimately feed through directly to the activities of Technology and Innovation Centres and industry, making a radical and much-needed impact on the production of many different high-value products. By working together in this way, the UK research community will contribute to the competitiveness of companies across a variety of important sectors including pharmaceuticals, fine chemicals, dyes & pigments, energy, food and drink.

"We will carry out an innovative programme of research and, by close engagement with our industrial colleagues, ensure that the exciting new research programme is targeted to areas of real national need. In this way, for example, the research carried out with the support of this award will benefit patients through better medicines, produced more efficiently, at lower cost and more sustainably.

"In addition to improving the way drug substances are produced, work within the Centre will also explore alternative approaches to manufacturing the medicines in which drugs are delivered to patients. This could include alternatives to the traditional tablet that are also safe and effective but are more straightforward to make. Whilst we have a significant focus around pharmaceuticals, we have many different chemical sectors involved in the Centre, which will ensure the broad exploitation of the research outcomes across the chemical process industries."

The Centre is part of a 51 million investment by EPSRC in nine new centres officially launched today, through the UK-wide EPSRC Centre for Innovative Manufacturing programme. It has received a grant of 4.9 million from the programme and support worth a total of 1.8 million is also being contributed by industry, with a further 1 million coming from the universities to establish a new partnership between universities, industry and the public sector in this area.

It follows the launch of the 89 million Technology and Innovation Centre (TIC) at Strathclyde, a world-leading centre for transforming the way universities, business and industry collaborate to bring global competitive advantage to Scotland. The TIC and the new EPSRC centre will work in parallel, forging greater collaboration between academic researchers and industry.

The Centre for Innovative Manufacturing team of researchers, from seven leading UK universities and a range of industrial partners, harnesses skills and expertise in chemistry, chemical engineering, crystallisation, pharmaceutical sciences, manufacturing and operations management.

The group will:

  • Establish a World Class Research Centre to improve manufacturing performance in the UK process industries
  • Stimulate innovation and commercialisation of new technologies, particularly through SMEs and startup companies
  • Engage with global companies across a range of sectors
  • Develop international research and development networks

The EPSRC Centre will also play an important role in training the scientists of the future in an international centre of excellence.

The partners in the EPSRC Centre for Innovative Manufacturing project plan to secure further funding from a range of sources to grow the Centre and extend its activity beyond the initial five-year funding period. This builds on other recent success in this area for the collaborating universities- a grant from the Scottish Funding Council Horizon fund (SPIRIT), made in 2010, established an initial cohort of nine PhD students, three at Strathclyde.

Strathclyde has also invested a further 500,000 in a new multidisciplinary continuous processing lab, due to open this summer, and will bring together existing teams at the University and house a suite of state-of-the-art reactor devices for continuous manufacturing and crystallisation.


Contact: Paul Gallagher
University of Strathclyde

Related medicine news :

1. Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment
2. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
3. NYU Langone Medical Center cardiologists present at ACC 60th Annual Scientific Session
4. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
5. DSF Charitable Foundation gives $3.9M to CMUs Center or Nucleic Acids Science & Technology
6. Center director says FDA hitting milestones in tobacco law
7. The MMRF and John Theurer Cancer Center to host patient symposium
8. Elaine Fuchs awarded 2011 Albany Medical Center Prize
9. University of Michigan Cardiovascular Center studies new treatment for high-risk aortic patients
10. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
11. Scary Events Might Also Activate Brains Reward Center
Post Your Comments:
Related Image:
Center to revolutionize chemical manufacture is open for business 
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: